Ultragenyx Pharmaceutical Inc. (RARE) Social Stream
ULTRAGENYX PHARMACEUTICAL INC (RARE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RARE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-05 | 16 | $185 | $73 | $146.2 | $37.81 | 286.67% |
| 2022-01-11 | 16 | $185 | $73 | $143.933 | $37.81 | 280.67% |
| 2022-01-25 | 16 | $185 | $73 | $143 | $37.81 | 278.21% |
| 2022-01-26 | 16 | $185 | $73 | $142.4 | $37.81 | 276.62% |
| 2022-01-31 | 16 | $185 | $73 | $140 | $37.81 | 270.27% |
| 2022-02-11 | 16 | $185 | $73 | $140 | $37.81 | 270.27% |
| 2022-02-14 | 15 | $185 | $73 | $139.466 | $37.81 | 268.86% |
| 2022-04-26 | 15 | $186 | $73 | $139.533 | $37.81 | 269.04% |
| 2022-04-28 | 15 | $186 | $73 | $139.666 | $37.81 | 269.39% |
| 2022-05-05 | 15 | $186 | $73 | $138.461 | $37.81 | 266.2% |
| 2022-05-09 | 13 | $186 | $71 | $129.538 | $37.81 | 242.6% |
| 2022-05-18 | 13 | $186 | $71 | $126.846 | $37.81 | 235.48% |
| 2022-05-24 | 14 | $186 | $71 | $125 | $37.81 | 230.6% |
| 2022-07-28 | 13 | $185 | $70 | $121.5 | $37.81 | 221.34% |
| 2022-08-01 | 14 | $185 | $68 | $117 | $37.81 | 209.44% |
| 2022-08-02 | 14 | $185 | $60 | $112.666 | $37.81 | 197.98% |
| 2022-08-13 | 14 | $185 | $60 | $114.5 | $37.81 | 202.83% |
| 2022-09-17 | 13 | $185 | $60 | $117.266 | $37.81 | 210.15% |
| 2022-10-12 | 11 | $185 | $60 | $117.266 | $37.81 | 210.15% |
| 2022-10-21 | 13 | $185 | $50 | $112 | $37.81 | 196.22% |
| 2022-10-25 | 13 | $185 | $50 | $111.5 | $37.81 | 194.9% |
| 2022-11-03 | 14 | $164 | $49 | $102.312 | $37.81 | 170.6% |
| 2022-11-04 | 14 | $143 | $49 | $98.125 | $37.81 | 159.52% |
The Trend in the Analyst Price Target
Over the past 52 weeks, RARE's average price target has gone down $45.2.
RARE reports an average of 130.25% for its upside potential over the past 43 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-26 | 16 | 185 | 73 | 142.400 | 68.11 | 109.07% |
| 2022-04-19 | 15 | 186 | 73 | 139.533 | 78.10 | 78.66% |
| 2022-08-02 | 14 | 185 | 60 | 112.666 | 51.28 | 119.71% |
| 2022-10-13 | 13 | 185 | 50 | 112.000 | 39.65 | 182.47% |
| 2022-10-25 | 13 | 185 | 50 | 111.500 | 39.39 | 183.07% |
RARE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.46 | 10 | 1 | 3 | 0 | 0 | 14 |
The Trend in the Broker Recommendations
Over the past 123 days, RARE's average broker recommendation rating improved by 0.19.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of stocks in the large market cap category, ULTRAGENYX PHARMACEUTICAL INC's upside potential (average analyst target price relative to current price) is higher than 2526.4% of them.
- ULTRAGENYX PHARMACEUTICAL INC's number of analysts covering the stock is greater than 2425.59% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, ULTRAGENYX PHARMACEUTICAL INC's average analyst price target is greater than 2394.48% of them.
- ULTRAGENYX PHARMACEUTICAL INC's variance in analysts' estimates is lower than -2247.59% of stocks in the large market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ULTRAGENYX PHARMACEUTICAL INC are ALKS, ALNY, and UTHR.
View All Top Stocks by Price Target
What is the outlook for RARE? Use POWR Ratings for clearer insight into price direction.